These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat. Zöller M, Matzku S. Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412 [Abstract] [Full Text] [Related]
35. Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood. Lee SH, Crocker P, Gordon S. J Exp Med; 1986 Jan 01; 163(1):54-74. PubMed ID: 3001215 [Abstract] [Full Text] [Related]
36. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells]. Akiyama Y, Yamasaki T, Fukuda M, Moritake K. No To Shinkei; 1995 Apr 01; 47(4):349-55. PubMed ID: 7772402 [Abstract] [Full Text] [Related]
38. RNA synthesis in activated macrophages I. Poly(I) X poly(C)-induced triggering of cytolytic activity is associated with decrease in RNA synthesis. Varesio L, Issaq HJ, Taramelli D. Eur J Immunol; 1983 Dec 01; 13(12):959-64. PubMed ID: 6662187 [Abstract] [Full Text] [Related]
39. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages. Bara S, Lint TF. J Immunol; 1987 Feb 15; 138(4):1303-9. PubMed ID: 3100634 [Abstract] [Full Text] [Related]
40. Immunological studies on chronic active hepatitis: possible involvement of macrophage-mediated cytotoxicity in its immunopathogenesis. Mizoguchi Y, Shiba T, Ohnishi F, Monna T, Yamamoto S, Morisawa S. Hepatogastroenterology; 1981 Oct 15; 28(5):250-3. PubMed ID: 7047338 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]